DLB
Dolby Laboratories, Inc.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DLB
this stock
Dolby Laboratories, Inc.
|
$7.59B | -19.9% | +10.3% | — | 6.1% |
|
CTAS
Cintas Corp
|
$72.56B | -3.3% | +6.4% | — | 3.0% |
|
RELX
Relx PLC
|
$55.89B | -21.0% | — | — | 0.2% |
|
ULS
UL Solutions Inc.
|
$50.64B | +23.2% | +6.4% | 146.1 | 1.4% |
|
TRI
Thomson Reuters Corp /Can/
|
$38.94B | -30.3% | — | — | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DLB | -2.5% | -6.8% | -19.2% | -2.7% | -19.9% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -3.9% | -5.6% | -27.2% | -2.5% | -29.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.